Comparative Analysis of the Anticancer Activity of Angiotensin Receptor Blockers - Irbesartan and Telmisartan

Asian Journal of Pharmaceutical and Clinical Research - India
doi 10.22159/ajpcr.2018.v11i12.27948
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Innovare Academic Sciences Pvt Ltd

Related search

Comparative Assessment of Angiotensin Receptor Blockers in Different Clinical Settings

Vascular Health and Risk Management
2009English

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Maximising Antihypertensive Effects of Angiotensin II Receptor Blockers With Thiazide Diuretic Combination Therapy: Focus on Irbesartan/Hydrochlorothiazide

International Journal of Clinical Practice
Medicine
2007English

Angiotensin Receptor Blockers Use and the Risk of Lung Cancer: A Meta-Analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2015English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

The Effect of Angiotensin II Receptor Blockers on Hyperuricemia

Therapeutic Advances in Chronic Disease
Medicine
2015English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Are the Eutrophic Effects of Angiotensin Receptor Blockers Real?

Hypertension
Internal Medicine
2006English

The Comparative Efficacy and Safety of the Angiotensin Receptor Blockers in the Management of Hypertension and Other Cardiovascular Diseases

Drug Safety
ToxicologyPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy